These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34339675)

  • 1. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.
    Zhang R; Qu Y; Ji Z; Hao C; Su Y; Yao Y; Zuo W; Chen X; Yang M; Ma G
    Cell Mol Biol Lett; 2022 Jul; 27(1):55. PubMed ID: 35836108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21.
    Han J; Lin L; Fang Z; Ye B; Han X; Xu J; Han B; Min J; Qian J; Wu G; Wang Y; Liang G
    Theranostics; 2024; 14(16):6236-6248. PubMed ID: 39431010
    [No Abstract]   [Full Text] [Related]  

  • 5. METTL3-mediated m6A modification of OTUD1 aggravates press overload induced myocardial hypertrophy by deubiquitinating PGAM5.
    Huang K; Sun X; Xu X; Lu J; Zhang B; Li Q; Wang C; Ding S; Huang X; Liu X; Xu Z; Han L
    Int J Biol Sci; 2024; 20(12):4908-4921. PubMed ID: 39309432
    [No Abstract]   [Full Text] [Related]  

  • 6. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Ye B; Zhou H; Chen Y; Luo W; Lin W; Zhao Y; Han J; Han X; Huang W; Wu G; Wang X; Liang G
    Circ Res; 2023 Feb; 132(4):465-480. PubMed ID: 36722348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
    Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
    J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
    Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
    J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
    Shen T; Liu Y; Dong S; Xu X; Wang X; Li Y; Zhou L
    Peptides; 2021 Dec; 146():170669. PubMed ID: 34624429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
    Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
    Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
    He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
    Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N
    Gao XQ; Zhang YH; Liu F; Ponnusamy M; Zhao XM; Zhou LY; Zhai M; Liu CY; Li XM; Wang M; Shan C; Shan PP; Wang Y; Dong YH; Qian LL; Yu T; Ju J; Wang T; Wang K; Chen XZ; Wang YH; Zhang J; Li PF; Wang K
    Nat Cell Biol; 2020 Nov; 22(11):1319-1331. PubMed ID: 33020597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway.
    Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W
    Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
    Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.